Hepatic arterial infusion of autologous gamma/delta T cell for advanced hepatocellular carcinoma
Not Applicable
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000011184
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have: - Pulmonary fibrosis or interstitial pneumonia, including their history or predisposition; - Serious drug allergy; - Serious cardiac disease; - Active inflammatory bowel disease, - Active autoimmune disease; - Other cancers; - Active infections; - Pleural effusion or ascite that requires drainage procedure; - Pregnant, to be pregnant, or nursing mothers; - Positive for HIV or HTLV-1;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method In vivo dynamics (Gamma/delta T cells) Pharmacokinetics (Zoledronic acid) Efficacy Immunological responses